Bayer AG (FRA:BAYN) received a €118.00 ($125.53) target price from Warburg Research in a research report issued to clients and investors on Tuesday. The firm presently has a “buy” rating on the healthcare company’s stock.
BAYN has been the subject of a number of other reports. Nord/LB set a €108.00 ($114.89) price objective on Bayer AG and gave the company a “neutral” rating in a research note on Wednesday, February 22nd. DZ Bank AG reaffirmed a “neutral” rating on shares of Bayer AG in a research note on Tuesday, January 24th. equinet AG set a €118.00 ($125.53) price objective on Bayer AG and gave the company a “buy” rating in a research note on Thursday, February 9th. Independent Research GmbH set a €111.00 ($118.09) price objective on Bayer AG and gave the company a “neutral” rating in a research note on Thursday, March 2nd. Finally, Commerzbank Ag set a €118.00 ($125.53) price objective on Bayer AG and gave the company a “buy” rating in a research note on Friday, January 6th. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating and thirteen have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of €111.88 ($119.02).
Bayer AG (FRA:BAYN) opened at 104.491 on Tuesday. The firm’s 50-day moving average is €106.57 and its 200-day moving average is €99.15. Bayer AG has a 12 month low of €83.87 and a 12 month high of €112.11. The company has a market capitalization of €86.41 billion and a PE ratio of 19.208.
COPYRIGHT VIOLATION WARNING: This article was originally posted by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this article on another publication, it was copied illegally and republished in violation of United States and international copyright legislation. The original version of this article can be read at https://sportsperspectives.com/2017/04/21/warburg-research-analysts-give-bayer-ag-bayn-a-118-00-price-target-updated.html.
About Bayer AG
Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.